KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Capital Expenditures (2016 - 2025)

Repligen (RGEN) has disclosed Capital Expenditures for 16 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 47.17% to $8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.5 million, a 8.4% decrease, with the full-year FY2025 number at $23.5 million, down 8.4% from a year prior.
  • Capital Expenditures was $8.2 million for Q4 2025 at Repligen, down from $14.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $64.1 million in Q4 2021 to a low of -$60.9 million in Q4 2022.
  • A 5-year average of $6.1 million and a median of $6.3 million in 2024 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 1289.16% in 2021; the steepest drop was 1655.04% in 2021.
  • Repligen's Capital Expenditures stood at $64.1 million in 2021, then plummeted by 194.91% to -$60.9 million in 2022, then surged by 63.26% to -$22.4 million in 2023, then skyrocketed by 124.77% to $5.5 million in 2024, then surged by 47.17% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Capital Expenditures are $8.2 million (Q4 2025), $14.0 million (Q3 2025), and $504000.0 (Q2 2025).